Role of (68)Ga-DOTATOC PET/CT in the Evaluation of Primary Pulmonary Carcinoids.
10.3904/kjim.2010.25.4.386
- Author:
Tarun JINDAL
1
;
Arvind KUMAR
;
Balasubramanian VENKITARAMAN
;
Roman DUTTA
;
Rakesh KUMAR
Author Information
1. Department of General Surgery, All India Institute of Medical Sciences, New Delhi, India. arvindreena@gmail.com
- Publication Type:Original Article
- Keywords:
Fluorodeoxyglucose F18;
Gallium-68 DOTATOC;
Positron-emission tomography;
Receptors, somatostatin;
Carcinoids tumor
- MeSH:
Adolescent;
Adult;
Carcinoid Tumor/*diagnosis/radiography/radionuclide imaging;
Female;
Gallium Radioisotopes/*diagnostic use;
Humans;
Lung Neoplasms/*diagnosis/radiography/radionuclide imaging;
Male;
Middle Aged;
Octreotide/*analogs & derivatives/diagnostic use;
Positron-Emission Tomography/*methods;
Radiopharmaceuticals/*diagnostic use;
Retrospective Studies;
Tomography, X-Ray Computed/*methods
- From:The Korean Journal of Internal Medicine
2010;25(4):386-391
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND/AIMS: Although carcinoid tumors usually have good prognosis, early and specific diagnosis is important. Computed tomography and magnetic resonance imaging do not provide findings that are specific for carcinoids, and somatostatin receptor scintigraphy suffers from low spatial resolution. 18-Fluorodeoxyglucose positron emission tomography/computed tomography ((18)F-FDG PET/CT) has limited sensitivity for carcinoids due to low uptake of the marker. A PET/CT system that uses the somatostatin receptor-based PET tracer 1,4,7,10-tetraazacyclododecane-N(I),N(II),N(III),N(IIII)-tetraacetic acid (D)-Phe(1)-thy(3)-octreotide ((68)Ga-DOTATOC) has also been used in the evaluation of carcinoids, although information regarding its use for the detection of primary pulmonary carcinoids is limited. Thus, we investigated the value of (68)Ga-DOTATOC PET/CT for the diagnosis of primary pulmonary carcinoid tumors. METHODS: This was a retrospective analysis of patients with primary pulmonary tumors who underwent (68)Ga-DOTATOC PET/CT. All the patients had a histopathologic diagnosis of carcinoid. The rate of detection of primary pulmonary carcinoid tumors using (68)Ga-DOTATOC PET/CT was assessed. RESULTS: Twenty patients were diagnosed as having carcinoid, and 19 tumors showed significant uptake on (68)Ga-DOTATOC (detection rate, 95%). The maximal standardized uptake value (SUV(max)) ranged from 1.1 to 66, with a median value of 21.6. In one patient, (68)Ga-DOTATOC PET/CT revealed additional lesions. CONCLUSIONS: Our results demonstrate that (68)Ga-DOTATOC PET/CT is useful in the evaluation of primary pulmonary carcinoids and should be included in the diagnostic work-up of these patients.
